JPMorgan Chase & Co Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$4.22B |
| 2 |
iShares TIPS Bond ETF
TIP
|
+$1.55B |
| 3 |
JPMorgan BetaBuilders US Mid Cap Equity ETF
BBMC
|
+$1.31B |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.1B |
| 5 |
Wells Fargo
WFC
|
+$899M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$2.46B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.45B |
| 3 |
Tesla
TSLA
|
+$2.03B |
| 4 |
TSMC
TSM
|
+$1.66B |
| 5 |
Texas Instruments
TXN
|
+$1.62B |
Sector Composition
| 1 | Technology | 18.09% |
| 2 | Financials | 11.43% |
| 3 | Consumer Discretionary | 11.01% |
| 4 | Healthcare | 10.73% |
| 5 | Industrials | 7.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARCH
1601
DELISTED
Arch Resources, Inc.
ARCH
| $14.5M | ﹤0.01% |
331,180
+20,025
| +6% | +$877K |
|
|
EIGI
1602
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $14.5M | ﹤0.01% |
1,533,562
+1,499,702
| +4,429% | +$14.2M |
|
1603
Piper Sandler
PIPR
$6.12B
| $14.5M | ﹤0.01% |
143,417
+10,400
| +8% | +$1.05M |
|
1604
Ecopetrol
EC
$18.8B
| $14.4M | ﹤0.01% |
1,118,072
+61,878
| +6% | +$799K |
|
1605
Fulton Financial
FULT
$3.54B
| $14.4M | ﹤0.01% |
1,133,217
+820,931
| +263% | +$10.4M |
|
1606
PTC Therapeutics
PTCT
$4.85B
| $14.4M | ﹤0.01% |
235,528
+66,502
| +39% | +$4.06M |
|
1607
Vanguard Intermediate-Term Bond ETF
BIV
$24.3B
| $14.4M | ﹤0.01% |
154,746
+14,587
| +10% | +$1.35M |
|
1608
Krystal Biotech
KRYS
$4.16B
| $14.4M | ﹤0.01% |
239,312
+153,490
| +179% | +$9.21M |
|
1609
Pinnacle Financial Partners
PNFP
$7.55B
| $14.3M | ﹤0.01% |
222,484
+107,832
| +94% | +$6.94M |
|
1610
Popular Inc
BPOP
$8.34B
| $14.3M | ﹤0.01% |
253,102
-155,350
| -38% | -$8.75M |
|
|
TCRR
1611
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $14.2M | ﹤0.01% |
460,147
+196,273
| +74% | +$6.07M |
|
1612
eGain
EGAN
$220M
| $14.2M | ﹤0.01% |
1,204,399
+435,539
| +57% | +$5.14M |
|
1613
Vericel Corp
VCEL
$1.62B
| $14.2M | ﹤0.01% |
460,224
+207,166
| +82% | +$6.4M |
|
|
HMHC
1614
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $14.2M | ﹤0.01% |
4,261,718
-352,968
| -8% | -$1.18M |
|
1615
Protagonist Therapeutics
PTGX
$3.66B
| $14.2M | ﹤0.01% |
703,007
-81,711
| -10% | -$1.65M |
|
1616
Customers Bancorp
CUBI
$2.32B
| $14.2M | ﹤0.01% |
778,477
+6,377
| +0.8% | +$116K |
|
1617
Natural Resource Partners
NRP
$1.34B
| $14.1M | ﹤0.01% |
1,028,351
| – | – |
|
|
UCB
1618
United Community Banks, Inc.
UCB
$3.94B
| $14.1M | ﹤0.01% |
495,694
-33,285
| -6% | -$947K |
|
1619
FirstCash
FCFS
$6.49B
| $14.1M | ﹤0.01% |
201,047
-4,969
| -2% | -$348K |
|
1620
Owens & Minor
OMI
$412M
| $14.1M | ﹤0.01% |
520,482
-1,563,727
| -75% | -$42.3M |
|
1621
First Trust Dorsey Wright Focus 5 ETF
FV
$3.73B
| $14.1M | ﹤0.01% |
347,765
-5,399
| -2% | -$218K |
|
1622
Bank of N.T. Butterfield & Son
NTB
$1.89B
| $14.1M | ﹤0.01% |
451,251
+73,404
| +19% | +$2.29M |
|
1623
Vishay Intertechnology
VSH
$2.07B
| $14.1M | ﹤0.01% |
678,557
-107,363
| -14% | -$2.22M |
|
1624
TFI International
TFII
$7.77B
| $14M | ﹤0.01% |
271,717
+25,041
| +10% | +$1.29M |
|
|
ABST
1625
DELISTED
Absolute Software Corporation Common Stock
ABST
| $14M | ﹤0.01% |
+1,172,344
| New | +$14M |
|